The 12 closest competitors and alternatives to Peptilogics, Inc. among biotech companies — ranked by similarity to what Peptilogics, Inc. actually does, not by market-cap band.
Subscribe to see Peptilogics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Peptilogics, Inc. is a biotechnology company founded in 2013 and headquartered in Pittsburgh, Pennsylvania. The company utilizes advanced computational and biological approaches to discover and develop novel peptide therapeutics.
Peptilogics, Inc. is a biotech company headquartered in United States. It has raised at least $40.9M across the 4 funding rounds on record. Its most recent funding round raised $35.8M in December 2020. Xcout recorded 3 job postings from Peptilogics, Inc. in the last 90 days.
At least $40.9M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $35.8M | — | |
| SEC Form D filing | $4M | — | |
| SEC Form D filing | $753,999 | — | |
| Seed | $417,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 3 job postings from Peptilogics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Peptilogics, Inc.'s hiring signals →
Ranked by semantic similarity — how close each company is to Peptilogics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Meddenovo Drug Design is a Lyon, France-based biotechnology company operating at the intersection of AI and life sciences to build advanced computational technologies for peptide drug discovery.
Biotechnology
Biolojic Design is an Israeli biotechnology company that uses computational modeling and artificial intelligence to design and engineer antibodies and other therapeutic proteins. It develops drug candidates and collaborates with pharmaceutical and biotechnology companies seeking novel biologic medicines.
Biotechnology
Protagonist Therapeutics is a clinical-stage biopharmaceutical company headquartered at the Pacific Research Center in Newark, California, focused on peptide drug discovery.
Biotechnology
Parabilis Medicines is a biopharmaceutical company that develops ultra-tunable peptide therapeutics utilizing its proprietary Helicon platform. The company focuses on creating novel medicines to target historically undruggable conditions, primarily addressing cancer and other serious diseases with critical medical needs.
Biotechnology
Undaunted Bio, Inc. is an AI-driven drug repurposing company headquartered in Pittsburgh, United States, focused on treatments for neuropathic pain.
Similar biotech company
Launched in 2022 and headquartered in Seattle, Washington, Vilya is an AI peptide company co-founded by scientists from the Institute of Protein Design. The company uses artificial intelligence and synthetic biology to design novel macrocycle therapeutics inspired by nature.
Similar biotech company
PeptiDream Inc. functions as a biopharmaceutical enterprise, concentrating on the identification and progression of therapeutic compounds such as constrained peptides, small molecules, and peptide-drug conjugates. The company's unique product pipeline is underpinned by its proprietary Peptide Discovery Platform System (PDPS), an advanced technology specifically designed for the development of peptide-based drugs. Additionally, PeptiDream maintains an exclusive licensing and collaborative research partnership with Takeda Pharmaceutical Company Limited, aimed at creating peptide drug conjugates for the treatment of neuromuscular conditions. Established in 2006, the company's primary offices are situated in Kawasaki, Japan.
Biotechnology
Prellis Biologics, Inc. is a privately held biotechnology company headquartered in Berkeley, California, within the San Francisco Bay Area. It develops human antibody therapeutics and focuses on antibody discovery leveraging AI and immune diversity.
Similar biotech company
Nuritas uses a proprietary AI platform to discover, validate, and supply natural peptide ingredients for oral and topical health and wellness formulations. The company serves health and wellness brands by providing clinically-backed ingredients and custom peptide discovery services.
Biotechnology
Mebias Discovery, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, focused on drug discovery targeting G-protein coupled receptors.
Biotechnology
Protalys Therapeutics, Inc. is a private drug discovery and development company headquartered in San Diego, California, operating within the therapeutics and drug pipeline sector.
Biotechnology
pHLIP, Inc. is a privately held, clinical-stage biopharmaceutical company located in Kingston, Rhode Island, dedicated to improving patient outcomes using its proprietary pH-Low Insertion Peptide Platform.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Peptilogics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →